The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...

Pharmaceutical company Merck announced Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus. The company said it ...

Earlier this month, study results showed that molnupiravir, Merck’s investigational antiviral pill, cut hospitalization rates of Covid-19 patients by about half. Molnupiravir is the first oral ...

The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. WASHINGTON (AP) — In a potential leap forward in the global fight against the pandemic, drugmaker Merck ...

Merck (MRK) and Ridgeback Biotherapeutics announced today that their COVID-19 pill — the first oral antiviral of its kind — cut the risk of hospitalizations or deaths by half, and that they would ...

Britain granted conditional authorization on Thursday to the first pill shown to successfully treat COVID-19 so far. It also is the first country to OK the treatment from drugmaker Merck, although it ...